NCT05147701View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Eye DiseasesRetinitis PigmentosaDiabetic RetinopathyMacular DegenerationTraumatic Optic NeuropathyOptic Atrophy
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (2)

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

RECRUITING

Center for Investigation in Tissue Engineering and Cellular Therapy, Buenos Aires

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER